Pyridopyrimidine derivatives and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8664230
APP PUB NO 20120238587A1
SERIAL NO

13423950

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides novel substituted pyridopyrimidines represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3′ OH kinase family (PI3K) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SUNG KWANG MEDICAL FOUNDATION605-9 YEOKSAM-1DONG GANGNAM-GU SEOUL
CMG PHARMACEUTICAL CO LTDSEOUL 06064

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cho, Han Won Seoul, KR 4 30
Cho, Suk Young Seongnam-si, KR 10 119
Choi, Eun Kyung Seoul, KR 18 91
Gyorkos, Albert Charles Westminster, US 11 169
Hwang, Jung Jin Seoul, KR 14 65
Kim, Choung Soo Kyunggi-do, KR 6 29
Lee, Gilnam Seongnam-si, KR 8 87
Lim, Chul Soo Seoul, KR 4 25
Seo, Jeongbeob Seongnam-si, KR 52 1260

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 4, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00